Latest Health stories from Life.
Strategic angle: Sarepta Therapeutics’ next crop of medicines for muscular dystrophy appear to be safe and effective in early clinical trials, the company said.
Strategic angle: The study suggests that regular ejaculation could give male fertility 'a small but meaningful boost' - and that even a few days’ delay could matter for IVF success.
Strategic angle: An overview of deaths in ICE custody and health care issues during the Trump administration.
Strategic angle: Eli Lilly discusses the 'societal obligation' of GLP-1s amidst other biotech news.
Strategic angle: The acquisition aims to enhance Merck's portfolio with a promising leukemia treatment.
Strategic angle: A federal vaccine adviser departs ACIP, adults turn to AI chatbots for health info, and radiologists sift through deepfake X-rays.
Strategic angle: Robert Malone, an outspoken doctor and ally of RFK Jr., is stepping away from a panel of federal vaccine advisers after a federal judge blocked the panel’s work.
Strategic angle: Since the Supreme Court’s Dobbs decision, voters in 17 states have weighed in on ballot measures regarding abortion.
Strategic angle: CMS aims to transform fragmented care into a cohesive system for children with complex health needs.
Strategic angle: Settlement expected to save Americans up to $7 billion in out-of-pocket costs over the next decade.
Strategic angle: An analysis reveals that drugmakers penalized for kickbacks paid only a small fraction of their U.S. revenue from the drugs involved.
Strategic angle: Patrick Soon-Shiong, a controversial figure in the biotech industry, was accused by the FDA of making false and misleading claims about a cancer treatment.
Strategic angle: Trump's decisions serve as a test of how much sway RFK Jr.'s MAHA movement still has in the White House.
Strategic angle: An analysis of claims denials and appeals reveals significant challenges for consumers in the ACA Marketplace.
Strategic angle: Deepfake images can mislead viewers, upend elections, and instigate violence. They can also, researchers say, disrupt medical care.
Strategic angle: In this edition of STAT Health Tech: AI doctor startup raises fresh capital, and what Medicare chief Chris Klomp said at STAT Summit.
Strategic angle: In today's Readout newsletter: Gilead to acquire an immunology biotech and Merck partners with Flagship company on IBD targets.
Strategic angle: Comments from a top Trump administration health official highlight significant issues in the president’s drug pricing plans.
Strategic angle: In this excerpt from their new book “Whiplash,” David Blumenthal and James A. Morone describe how scientists became villains to MAGA.
Strategic angle: Diverging messages on the main effort to address U.S. drug prices point to a loophole in Trump's plan.